556 related articles for article (PubMed ID: 28420066)
21. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
[TBL] [Abstract][Full Text] [Related]
23. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
24. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
Urowitz MB; Gladman DD; Ibañez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcón GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):132-7. PubMed ID: 21954226
[TBL] [Abstract][Full Text] [Related]
25. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
26. Late-onset systemic lupus erythematosus: clinical features, course, and prognosis.
Tomic-Lucic A; Petrovic R; Radak-Perovic M; Milovanovic D; Milovanovic J; Zivanovic S; Pantovic S; Veselinovic M
Clin Rheumatol; 2013 Jul; 32(7):1053-8. PubMed ID: 23515605
[TBL] [Abstract][Full Text] [Related]
27. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Tarr T; Papp G; Nagy N; Cserép E; Zeher M
Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
[TBL] [Abstract][Full Text] [Related]
28. The rate and pattern of organ damage in late onset systemic lupus erythematosus.
Maddison P; Farewell V; Isenberg D; Aranow C; Bae SC; Barr S; Buyon J; Fortin P; Ginzler E; Gladman D; Hanly J; Manzi S; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G;
J Rheumatol; 2002 May; 29(5):913-7. PubMed ID: 12022349
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
Legge A; Doucette S; Hanly JG
J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
[TBL] [Abstract][Full Text] [Related]
30. Serum uric acid is associated with damage in patients with systemic lupus erythematosus.
Elera-Fitzcarrald C; Reátegui-Sokolova C; Gamboa-Cardenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Cucho-Venegas JM; Alfaro-Lozano J; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
Lupus Sci Med; 2020; 7(1):e000366. PubMed ID: 32153795
[TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus in Saudi children: long-term outcomes.
Al-Mayouf SM
Int J Rheum Dis; 2013 Feb; 16(1):56-60. PubMed ID: 23441773
[TBL] [Abstract][Full Text] [Related]
32. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
[TBL] [Abstract][Full Text] [Related]
33. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
[TBL] [Abstract][Full Text] [Related]
34. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study.
Mongkolchaiarunya J; Wongthanee A; Kasitanon N; Louthrenoo W
Adv Rheumatol; 2023 May; 63(1):20. PubMed ID: 37127712
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
37. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
[TBL] [Abstract][Full Text] [Related]
38. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.
Iaccarino L; Bettio S; Reggia R; Zen M; Frassi M; Andreoli L; Gatto M; Piantoni S; Nalotto L; Franceschini F; Larosa M; Fredi M; Punzi L; Tincani A; Doria A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):115-123. PubMed ID: 27390293
[TBL] [Abstract][Full Text] [Related]
39. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry.
Calvo-Alén J; Reveille JD; Rodríguez-Valverde V; McGwin G; Baethge BA; Friedman AW; Alarcón GS
Lupus; 2003; 12(5):377-85. PubMed ID: 12765301
[TBL] [Abstract][Full Text] [Related]
40. Clinical and serologic factors associated with lupus pleuritis.
Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
